These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

270 related articles for article (PubMed ID: 25761709)

  • 21. Universal varicella vaccination: efficacy trends and effect on herpes zoster.
    Goldman GS
    Int J Toxicol; 2005; 24(4):205-13. PubMed ID: 16126614
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Trends in varicella and herpes zoster epidemiology before and after the implementation of universal one-dose varicella vaccination over one decade in South Korea, 2003-2015.
    Choi JK; Park SH; Park S; Choi SM; Kim SH; Lee DG; Yoo JH; Choi JH; Kang JH
    Hum Vaccin Immunother; 2019; 15(11):2554-2560. PubMed ID: 31008679
    [No Abstract]   [Full Text] [Related]  

  • 23. Perspectives on optimal control of varicella and herpes zoster by mass routine varicella vaccination.
    Betta M; Laurino M; Pugliese A; Guzzetta G; Landi A; Manfredi P
    Proc Biol Sci; 2016 Mar; 283(1826):20160054. PubMed ID: 26984627
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Modeling the effects of varicella vaccination programs on the incidence of chickenpox and shingles.
    Schuette MC; Hethcote HW
    Bull Math Biol; 1999 Nov; 61(6):1031-64. PubMed ID: 17879870
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Different vaccination strategies in Spain and its impact on severe varicella and zoster.
    Gil-Prieto R; Walter S; Gonzalez-Escalada A; Garcia-Garcia L; Marín-García P; Gil-de-Miguel A
    Vaccine; 2014 Jan; 32(2):277-83. PubMed ID: 24275483
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Transmission of varicella zoster virus from individuals with herpes zoster or varicella in school and day care settings.
    Viner K; Perella D; Lopez A; Bialek S; Newbern C; Pierre R; Spells N; Watson B
    J Infect Dis; 2012 May; 205(9):1336-41. PubMed ID: 22454467
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Varicella Zoster Virus: A Common Cause of Stroke in Children and Adults.
    Amlie-Lefond C; Gilden D
    J Stroke Cerebrovasc Dis; 2016 Jul; 25(7):1561-1569. PubMed ID: 27138380
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Models for optimally controlling varicella and herpes zoster by varicella vaccination: a comparative study.
    Betta M; Landi A; Manfredi P; Laurino M
    Med Biol Eng Comput; 2019 May; 57(5):1121-1132. PubMed ID: 30652233
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The Epidemiology of Herpes Zoster After Varicella Immunization Under Different Biological Hypotheses: Perspectives From Mathematical Modeling.
    Guzzetta G; Poletti P; Merler S; Manfredi P
    Am J Epidemiol; 2016 Apr; 183(8):765-73. PubMed ID: 26994062
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The effect of vaccination on the epidemiology of varicella zoster virus.
    Edmunds WJ; Brisson M
    J Infect; 2002 May; 44(4):211-9. PubMed ID: 12099726
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Hope-Simpson's progressive immunity hypothesis as a possible explanation for herpes zoster incidence data.
    Guzzetta G; Poletti P; Del Fava E; Ajelli M; Scalia Tomba GP; Merler S; Manfredi P
    Am J Epidemiol; 2013 May; 177(10):1134-42. PubMed ID: 23548754
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Modelling the impact of one-dose vs. two-dose vaccination regimens on the epidemiology of varicella zoster virus in Australia.
    Gao Z; Gidding HF; Wood JG; MacIntyre CR
    Epidemiol Infect; 2010 Apr; 138(4):457-68. PubMed ID: 19781116
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The burden of hospitalisation for varicella and herpes zoster in England from 2004 to 2013.
    Hobbelen PH; Stowe J; Amirthalingam G; Miller L; van Hoek AJ
    J Infect; 2016 Sep; 73(3):241-53. PubMed ID: 27283754
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pathogenesis and current approaches to control of varicella-zoster virus infections.
    Gershon AA; Gershon MD
    Clin Microbiol Rev; 2013 Oct; 26(4):728-43. PubMed ID: 24092852
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effect of the varicella vaccination implementation on the development of herpes zoster in children and adolescents.
    Inan Yuksel E; Kara Polat A; Gore Karaali M; Koku Aksu AE; Gurel MS
    Dermatol Ther; 2021 Jul; 34(4):e14995. PubMed ID: 34031954
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The impact of the varicella vaccination program on herpes zoster epidemiology in the United States: a review.
    Reynolds MA; Chaves SS; Harpaz R; Lopez AS; Seward JF
    J Infect Dis; 2008 Mar; 197 Suppl 2():S224-7. PubMed ID: 18419401
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Modelling the impact of immunization on the epidemiology of varicella zoster virus.
    Brisson M; Edmunds WJ; Gay NJ; Law B; De Serres G
    Epidemiol Infect; 2000 Dec; 125(3):651-69. PubMed ID: 11218215
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Decreased varicella and increased herpes zoster incidence at a sentinel medical deputising service in a setting of increasing varicella vaccine coverage in Victoria, Australia, 1998 to 2012.
    Kelly HA; Grant KA; Gidding H; Carville KS
    Euro Surveill; 2014 Oct; 19(41):. PubMed ID: 25345520
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The safety profile of varicella vaccine: a 10-year review.
    Galea SA; Sweet A; Beninger P; Steinberg SP; Larussa PS; Gershon AA; Sharrar RG
    J Infect Dis; 2008 Mar; 197 Suppl 2():S165-9. PubMed ID: 18419392
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Epidemiology of pediatric herpes zoster after varicella infection: a population-based study.
    Wen SY; Liu WL
    Pediatrics; 2015 Mar; 135(3):e565-71. PubMed ID: 25713285
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.